Ultrahuman raises $70 Mn from Qualcomm, Alpha Wave, Nexus and others
2 min read
- Published: September 7, 2026
A wearable technology startup called Ultrahuman has secured $70 million in backing from a fundraising round headed by Qualcomm Ventures, with support from Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, Alteria, and several other partners.
Key Takeaways
- Wearable-tech startup Ultrahuman raised $70 million led by Qualcomm Ventures, with Labcorp, Alpha Wave and Nexus Venture Partners participating.
- The Bengaluru company will use funds for R&D in sensing, AI, miniature electronics and health algorithms.
- The round reportedly values Ultrahuman around $363 million, a sharp jump from its Series B valuation.
- Ultrahuman aims to evolve from a health-wearable maker into a broader human-computer interface platform.
Located in Bengaluru, the company indicated that the new capital would fund research and development in domains ranging from sensing and artificial intelligence to miniature electronics, health-oriented algorithms, and scientific investigation.
Entrackr provided exclusive coverage of the round on Tuesday, citing Ultrahuman’s recent regulatory disclosures.
Earlier sector analyses had estimated the company’s post-money valuation around $363 million, marking a substantial leap from its previous Series B figure. Historically, Ultrahuman had previously closed a $35 million Series B round and a $17.5 million Series A round during October 2022.
The firm aims to pivot its trajectory from a dedicated health-wearing device into a broad human-computer interface built upon data originating from the human body. Its unified platform aggregates inputs from the Ultrahuman Ring, Blood Vision, M1/M2 Live continuous glucose monitors, Ultrahuman Home, and the Jade AI system, collectively tracing physiological, biochemical, metabolic, and environmental parameters.
Furthermore, the company has initiated research ventures like Pulsomics, an opt-in platform facilitating contributions from Ring users in medical studies. Current project focus areas include sleep duration, VO₂ max performance, and glucose handling. Supplementary features comprise atrial fibrillation detection, cycle and ovulation prediction, cardiovascular fitness aging, and PowerPlugs providing extra health-centric utilities.
Financially, Ultrahuman reported revenue totaling Rs 565 crore and a post-tax profit of Rs 73 crore for fiscal year 2025. With guidance projecting revenue nearing Rs 1,000 crore for FY26 as the entity eye-levels expanding its footprint globally, the momentum continues forward.
Founders Mohit Kumar and Vatsal Singhal launched the company, who had originally sold their logistics venture, Runnr, to Zomato in 2017.
